Biotheryx, Inc. Alternatives & Competitors
12 companies similar to Biotheryx, Inc. — Degrading proteins. Saving lives. Building the leader in next-generation targete...
Companies similar to Biotheryx, Inc.
Plexium
Pushing the Boundaries of Targeted Protein Degradation to Improve Lives
San Diego, United States
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly select...
Boston, United States
Degron Therapeutics
Aims to become a global leader in the discovery and development of molecular glue degrader...
San Diego, United States
Advanced BioDesign
Overcoming Tumor Drug Resistance
Saint-priest, France
Rival Readout
Competing with Biotheryx, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Arvinas
Leading the way in targeted protein degradation therapeutics
New Haven, United States
Inspirna, Inc.
Converting cancer to a manageable, chronic condition
New York, United States
Molecure
Fate can be altered.
Warsaw, Poland
Ribon Therapeutics
Pioneering Therapeutics Targeting Cellular Stress Pathways
Cambridge, United States
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to t...
United Kingdom
Molecular Templates
Engineering the Next Generation of Therapeutics
Austin, United States
Eikon Therapeutics
Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and develo...
Millbrae, United States
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditio...
About Biotheryx, Inc.
Biotheryx, Inc., founded in 2008, is positioning itself as a leader in next-generation targeted protein degradation, operating from its headquarters in the United States. The company's slogan, "Degrading proteins. Saving lives.", underlines its commitment to pioneering advancements in the field.
Development of protein degraders, PRODEGY platform for drug discovery, Clinical trials in oncology and inflammatory disorders
Healthcare Providers, Pharmaceutical Companies, Cancer Research Institutions, Patients with cancer and inflammatory diseases
Protein Degradation, Bifunctional Degraders, Molecular Glues, Cancer Treatment, Inflammatory Diseases, CDK4/6 Degraders, SOS1 Degraders, KRAS Mutant Cancers, PRODEGY Platform, Cereblon Modulators, Small Molecule Therapeutics, E3 Ligase Inhibition, Clinical-Stage Biopharmaceutical, PDE4 Degraders, Innovative Drug Design
B2B, Platform
Licensing, Performance Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Biotheryx, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Biotheryx, Inc. on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
